Transhiatal esophagectomy: A safe alternative for selected patients

Thomas M. Daniel, Kirk J. Fleischer, Terry L. Flanagan, Curtis G. Tribble, Irving L. Kron

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

One hundred one consecutive patients underwent an esophagectomy with gastric interposition for benign and malignant processes from January 1982 through July 1990. Seventy-seven underwent transhiatal esophagectomy and 24, transthoracic esophagectomy. Multivariate analysis was performed comparing the hospitalization experience of the two groups. There was no significant difference found between the mean intraoperative blood loss for transhiatal esophagectomy (770 ± 105 mL) and that of transthoracic esophagectomy (700 ± 175 mL). There was a significant difference between operative time, with transhiatal esophagectomy averaging 5.4 hours and transthoracic esophagectomy averaging 7.3 hours. Postoperative stay was not significantly different although there was a wide range of values for the transthoracic esophagectomy group. An 8% operative mortality was experienced by both groups. There were a significant number of minor anastomotic leaks at the cervical anastomotic level for the transhiatal esophagectomy group, but all responded to nonoperative management. The highest morbidity and mortality were seen in the subgroup of transhiatal esophagectomies done for laryngocervical malignancies. The lowest morbidity and mortality were seen in the subgroup of 12 patients who underwent transhiatal esophagectomy for nonmalignant esophageal conditions. Transhiatal esophagectomy appears to be a safe alternative for early intrathoracic esophageal malignancies at any level, for bulky distal esophageal lesions, and for benign conditions requiring total esophagectomy.

Original languageEnglish (US)
Pages (from-to)686-690
Number of pages5
JournalThe Annals of Thoracic Surgery
Volume54
Issue number4
DOIs
StatePublished - Oct 1992
Externally publishedYes

Fingerprint

Esophagectomy
Mortality
Morbidity
Anastomotic Leak
Operative Time
Neoplasms
Stomach
Hospitalization
Multivariate Analysis

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Transhiatal esophagectomy : A safe alternative for selected patients. / Daniel, Thomas M.; Fleischer, Kirk J.; Flanagan, Terry L.; Tribble, Curtis G.; Kron, Irving L.

In: The Annals of Thoracic Surgery, Vol. 54, No. 4, 10.1992, p. 686-690.

Research output: Contribution to journalArticle

Daniel, Thomas M. ; Fleischer, Kirk J. ; Flanagan, Terry L. ; Tribble, Curtis G. ; Kron, Irving L. / Transhiatal esophagectomy : A safe alternative for selected patients. In: The Annals of Thoracic Surgery. 1992 ; Vol. 54, No. 4. pp. 686-690.
@article{6b72c50bd4164edfbdb490483b25425b,
title = "Transhiatal esophagectomy: A safe alternative for selected patients",
abstract = "One hundred one consecutive patients underwent an esophagectomy with gastric interposition for benign and malignant processes from January 1982 through July 1990. Seventy-seven underwent transhiatal esophagectomy and 24, transthoracic esophagectomy. Multivariate analysis was performed comparing the hospitalization experience of the two groups. There was no significant difference found between the mean intraoperative blood loss for transhiatal esophagectomy (770 ± 105 mL) and that of transthoracic esophagectomy (700 ± 175 mL). There was a significant difference between operative time, with transhiatal esophagectomy averaging 5.4 hours and transthoracic esophagectomy averaging 7.3 hours. Postoperative stay was not significantly different although there was a wide range of values for the transthoracic esophagectomy group. An 8{\%} operative mortality was experienced by both groups. There were a significant number of minor anastomotic leaks at the cervical anastomotic level for the transhiatal esophagectomy group, but all responded to nonoperative management. The highest morbidity and mortality were seen in the subgroup of transhiatal esophagectomies done for laryngocervical malignancies. The lowest morbidity and mortality were seen in the subgroup of 12 patients who underwent transhiatal esophagectomy for nonmalignant esophageal conditions. Transhiatal esophagectomy appears to be a safe alternative for early intrathoracic esophageal malignancies at any level, for bulky distal esophageal lesions, and for benign conditions requiring total esophagectomy.",
author = "Daniel, {Thomas M.} and Fleischer, {Kirk J.} and Flanagan, {Terry L.} and Tribble, {Curtis G.} and Kron, {Irving L.}",
year = "1992",
month = "10",
doi = "10.1016/0003-4975(92)91012-X",
language = "English (US)",
volume = "54",
pages = "686--690",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Transhiatal esophagectomy

T2 - A safe alternative for selected patients

AU - Daniel, Thomas M.

AU - Fleischer, Kirk J.

AU - Flanagan, Terry L.

AU - Tribble, Curtis G.

AU - Kron, Irving L.

PY - 1992/10

Y1 - 1992/10

N2 - One hundred one consecutive patients underwent an esophagectomy with gastric interposition for benign and malignant processes from January 1982 through July 1990. Seventy-seven underwent transhiatal esophagectomy and 24, transthoracic esophagectomy. Multivariate analysis was performed comparing the hospitalization experience of the two groups. There was no significant difference found between the mean intraoperative blood loss for transhiatal esophagectomy (770 ± 105 mL) and that of transthoracic esophagectomy (700 ± 175 mL). There was a significant difference between operative time, with transhiatal esophagectomy averaging 5.4 hours and transthoracic esophagectomy averaging 7.3 hours. Postoperative stay was not significantly different although there was a wide range of values for the transthoracic esophagectomy group. An 8% operative mortality was experienced by both groups. There were a significant number of minor anastomotic leaks at the cervical anastomotic level for the transhiatal esophagectomy group, but all responded to nonoperative management. The highest morbidity and mortality were seen in the subgroup of transhiatal esophagectomies done for laryngocervical malignancies. The lowest morbidity and mortality were seen in the subgroup of 12 patients who underwent transhiatal esophagectomy for nonmalignant esophageal conditions. Transhiatal esophagectomy appears to be a safe alternative for early intrathoracic esophageal malignancies at any level, for bulky distal esophageal lesions, and for benign conditions requiring total esophagectomy.

AB - One hundred one consecutive patients underwent an esophagectomy with gastric interposition for benign and malignant processes from January 1982 through July 1990. Seventy-seven underwent transhiatal esophagectomy and 24, transthoracic esophagectomy. Multivariate analysis was performed comparing the hospitalization experience of the two groups. There was no significant difference found between the mean intraoperative blood loss for transhiatal esophagectomy (770 ± 105 mL) and that of transthoracic esophagectomy (700 ± 175 mL). There was a significant difference between operative time, with transhiatal esophagectomy averaging 5.4 hours and transthoracic esophagectomy averaging 7.3 hours. Postoperative stay was not significantly different although there was a wide range of values for the transthoracic esophagectomy group. An 8% operative mortality was experienced by both groups. There were a significant number of minor anastomotic leaks at the cervical anastomotic level for the transhiatal esophagectomy group, but all responded to nonoperative management. The highest morbidity and mortality were seen in the subgroup of transhiatal esophagectomies done for laryngocervical malignancies. The lowest morbidity and mortality were seen in the subgroup of 12 patients who underwent transhiatal esophagectomy for nonmalignant esophageal conditions. Transhiatal esophagectomy appears to be a safe alternative for early intrathoracic esophageal malignancies at any level, for bulky distal esophageal lesions, and for benign conditions requiring total esophagectomy.

UR - http://www.scopus.com/inward/record.url?scp=0026460949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026460949&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(92)91012-X

DO - 10.1016/0003-4975(92)91012-X

M3 - Article

C2 - 1417225

AN - SCOPUS:0026460949

VL - 54

SP - 686

EP - 690

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -